Deutsche Bank’s Greenwich LifeSciences GLSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$126K Buy
5,351
+189
+4% +$4.6K ﹤0.01% 3422
2026
Q1
$124K Sell
5,162
-889
-15% -$23.2K ﹤0.01% 3183
2025
Q4
$127K Sell
6,051
-15,451
-72% -$163K ﹤0.01% 3218
2025
Q3
$214K Buy
+21,502
New +$243K ﹤0.01% 3033
2022
Q2
Sell
-2,192
Closed -$43K 4198
2022
Q1
$43K Sell
2,192
-260
-11% -$5.25K ﹤0.01% 3882
2021
Q4
$60K Buy
2,452
+130
+6% +$4.35K ﹤0.01% 3901
2021
Q3
$91K Sell
2,322
-74
-3% -$3.09K ﹤0.01% 3935
2021
Q2
$108K Buy
+2,396
New +$90.6K ﹤0.01% 4108

Other funds holding GLSI

Deutsche Bank's GLSI Position: Q2 2026 in Review

Deutsche Bank increased its Greenwich LifeSciences (GLSI) stake by 3.7% in Q2 2026, buying an estimated $4.6K and bringing the position to 5,351 shares worth $126K. The position accounts for ﹤0.01% of the portfolio, ranked #3422.

Deutsche Bank first reported a position in GLSI in Q2 2021 and has held it in 8 quarters since. The position peaked at $214K in Q3 2025. 58 funds tracked by Wall St. Rank hold GLSI as of Q2 2026.

  • Deutsche Bank held 5,351 shares of Greenwich LifeSciences worth $126K as of Q2 2026.
  • Deutsche Bank bought 189 Greenwich LifeSciences shares in Q2 2026, an estimated $4.6K.
  • Greenwich LifeSciences made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #3422 holding.
  • Deutsche Bank first reported a position in Greenwich LifeSciences in Q2 2021 and has held it in 8 quarters since.
  • Deutsche Bank's Greenwich LifeSciences position peaked at $214K in Q3 2025.
  • 58 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.